Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia
Xiaokang Jia, Wen Xu, Lei Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 153

Showing 1-25 of 153 citing articles:

Bacteroides vulgatus Ameliorates Lipid Metabolic Disorders and Modulates Gut Microbial Composition in Hyperlipidemic Rats
Mingchao Xu, Ruiting Lan, Lei Qiao, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 44
The emerging role of the small intestinal microbiota in human health and disease
Renate A.A.A. Ruigrok, Rinse K. Weersma, Arnau Vich Vila
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 40
The Role of Short Chain Fatty Acids in Inflammation and Body Health
Yuhang Du, Changhao He, Yongcheng An, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7379-7379
Open Access | Times Cited: 32
Curcumin modulated gut microbiota and alleviated renal fibrosis in 5/6 nephrectomy-induced chronic kidney disease rats
Li Cheng, Xulong Chen, Jingchun Yao, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0314029-e0314029
Open Access | Times Cited: 1
The oral-gut microbiota axis: a link in cardiometabolic diseases
Qian Xu, Wenting Wang, Yiwen Li, et al.
npj Biofilms and Microbiomes (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
A comprehensive quality control pipeline in human microbiome research for large population studies
Ruolin Li, Joost Verlouw, Cindy G. Boer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access | Times Cited: 1
Probiotic-fermented rice buckwheat alleviates high-fat diet-induced hyperlipidemia in mice by suppressing lipid accumulation and modulating gut microbiota
Jing Yan, Qiuyan Xue, Chen Wen-yi, et al.
Food Research International (2022) Vol. 155, pp. 111125-111125
Closed Access | Times Cited: 55
Exploring the gut microbiota: lifestyle choices, disease associations, and personal genomics
Sharlize Pedroza Matute, Sasitaran Iyavoo
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 32
Treatment of Dyslipidemia through Targeted Therapy of Gut Microbiota
Brandon Flaig, Rachel Garza, Bhavdeep Singh, et al.
Nutrients (2023) Vol. 15, Iss. 1, pp. 228-228
Open Access | Times Cited: 28
Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies
Muthukumaran Jayachandran, Shen Qu
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 6, pp. 1189-1204
Closed Access | Times Cited: 27
Ginsenoside Rb1, Compound K and 20(S)-Protopanaxadiol Attenuate High-Fat Diet-Induced Hyperlipidemia in Rats via Modulation of Gut Microbiota and Bile Acid Metabolism
Kang-Xi Zhang, Yue Zhu, Shuxia Song, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 1108-1108
Open Access | Times Cited: 9
Targeting Gut Microbiota With Natural Polysaccharides: Effective Interventions Against High-Fat Diet-Induced Metabolic Diseases
Chao‐Yue Sun, Zuo-Liang Zheng, Cunwu Chen, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 34
Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites
Mingzhe Zhu, Xue Wang, Kai Wang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 19
Lysimachia christinae polysaccharide attenuates diet-induced hyperlipidemia via modulating gut microbes-mediated FXR–FGF15 signaling pathway
Yong-Fei Zhou, Jiaojiao Nie, Chao Shi, et al.
International Journal of Biological Macromolecules (2023) Vol. 248, pp. 125725-125725
Closed Access | Times Cited: 17
Recent insights of obesity-induced gut and adipose tissue dysbiosis in type 2 diabetes
Debarun Patra, Dipanjan Banerjee, Palla Ramprasad, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 17
The lipid-lowering effects of fenugreek gum, hawthorn pectin, and burdock inulin
Yi Wang, Yu Zheng, Yi Liu, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 16
Management of Cardiovascular Diseases by Short-Chain Fatty Acid Postbiotics
Seyed Sadeq Mousavi Ghahfarrokhi, Mohamadsadegh Mohamadzadeh, Nasrin Samadi, et al.
Current Nutrition Reports (2024) Vol. 13, Iss. 2, pp. 294-313
Closed Access | Times Cited: 6
Microbiome-Metabolome Analysis Insight into the Effects of the Extract of Phyllanthus emblica L. on High-Fat Diet-Induced Hyperlipidemia
Jiahao Wang, Jijing Dong, Furong Zhong, et al.
Metabolites (2024) Vol. 14, Iss. 5, pp. 257-257
Open Access | Times Cited: 6
A study on the association between gut microbiota, inflammation, and type 2 diabetes
Nannan Liu, Xuehua Yan, Bohan Lv, et al.
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access | Times Cited: 5
Theabrownin as a Potential Prebiotic Compound Regulates Lipid Metabolism via the Gut Microbiota, Microbiota-Derived Metabolites, and Hepatic FoxO/PPAR Signaling Pathways
Yue Xiao, Dongmei Yang, Haoran Zhang, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 15, pp. 8506-8520
Closed Access | Times Cited: 5
The Association between the Firmicutes/Bacteroidetes Ratio and Body Mass among European Population with the Highest Proportion of Adults with Obesity: An Observational Follow-Up Study from Croatia
Andrija Karačić, Ira Renko, Željko Krznarić, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2263-2263
Open Access | Times Cited: 5
Meta-analysis of the effects of probiotics on hyperlipidemia
Yuanyue Yao, Qing Hong, Siqi Ding, et al.
Current Research in Food Science (2024) Vol. 9, pp. 100885-100885
Open Access | Times Cited: 5
Causal Association between the Gut Microbiota and Chronic Kidney Disease: A Two-Sample Mendelian Randomization Study in a Chinese Population
Wenjian Lin, Zixin Liang, Junxuan Fang, et al.
(2025)
Closed Access
Sargassum fusiforme and its fucoidan alleviates high-fat diet induced obesity associated with the improvement of the gut microbiota profile
Xiaoyu Ling, Zhengyang Li, Ning Su, et al.
Journal of Functional Foods (2025) Vol. 125, pp. 106686-106686
Open Access
Coix Seed Extract Attenuates Glycolipid Metabolism Disorder in Hyperlipidemia Mice Through PPAR Signaling Pathway Based on Metabolomics and Network Pharmacology
Min Wang, Tianming Yang, Yongjing Xiang, et al.
Foods (2025) Vol. 14, Iss. 5, pp. 770-770
Open Access
Page 1 - Next Page

Scroll to top